Velocity Clinical Research

Rockville, Maryland 20854

1 studies enrolling now · 7 studies all time

What they study most

COVID-19, Epstein-Barr Virus Infection, Influenza, Norovirus Acute Gastroenteritis, OSA, Obesity or Overweight, SARS-CoV-2

Studies at this site

• A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults — Completed
• Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions — Completed
• Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age — Running, not enrolling
• A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants — Running, not enrolling
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation